765
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Group A rotavirus genotypes circulating prior to implementation of a National Immunization Program in Estonia

, , , , , , , , , , , , , , , & show all
Pages 465-469 | Published online: 28 Feb 2012

References

  • Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565 - 72; http://dx.doi.org/10.3201/eid0905.020562; PMID: 12737740
  • Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, the WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. [Epub ahead of print] Lancet Infect Dis 2011; 24; PMID: 22030330
  • Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006; 25:Suppl S7 - 11; http://dx.doi.org/10.1097/01.inf.0000197622.98559.01; PMID: 16397431
  • Giammanco MD, Coniglio MA, Pignato S, Giammanco G. An economic analysis of rotavirus vaccination in Italy. Vaccine 2009; 27:3904 - 11; http://dx.doi.org/10.1016/j.vaccine.2009.04.002; PMID: 19446934
  • Jit M, Bilcke J, Mangen MJ, Salo H, Melliez H, Edmunds WJ, et al. The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. Vaccine 2009; 27:6121 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.08.030; PMID: 19715781
  • Mangen MJ, van Duynhoven YT, Vennema H, van Pelt W, Havelaar AH, de Melker HE. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?. Vaccine 2010; 28:2624 - 35; http://dx.doi.org/10.1016/j.vaccine.2010.01.014; PMID: 20109593
  • Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15:29 - 56; http://dx.doi.org/10.1002/rmv.448; PMID: 15484186
  • Kirkwood CD, Boniface K, Barnes GL, Bishop RF. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia. Pediatr Infect Dis J 2011; 30:Suppl S48 - 53; http://dx.doi.org/10.1097/INF.0b013e3181fefd90; PMID: 21183840
  • Carvalho-Costa FA, Volotão EdeM, de Assis RM, Fialho AM, de Andrade JdaS, Rocha LN, et al. Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009. Pediatr Infect Dis J 2011; 30:Suppl S35 - 41; http://dx.doi.org/10.1097/INF.0b013e3181fefd5f; PMID: 21048523
  • Zeller M, Rahman M, Heylen E, De Coster S, De Vos S, Arijs I, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine 2010; 28:7507 - 13; http://dx.doi.org/10.1016/j.vaccine.2010.09.004; PMID: 20851085
  • Ogilvie I, Khoury H, El Khoury AC, Goetghebeur MM. Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe: serotype distribution and burden of illness. Hum Vaccin 2011; 7:523 - 33; http://dx.doi.org/10.4161/hv.7.5.14819; PMID: 21422818
  • Ginevskaya VA, Amitina NN, Eremeeva TP, Shirman GA, Priimägi LS, Drozdov SG. Electropherotypes and serotypes of human rotavirus in Estonia in 1989-1992. Arch Virol 1994; 137:199 - 207; http://dx.doi.org/10.1007/BF01311188; PMID: 7979994
  • Forster J, Guarino A, Parez N, Moraga F, Román E, Mory O, et al, and the Rotavirus Study Group. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics 2009; 123:e393 - 400; http://dx.doi.org/10.1542/peds.2008-2088; PMID: 19254975
  • Grassi T, Bagordo F, Cavallaro A, Guido M, Malaventura C, Gabutti G, et al. Sequence analysis of human rotavirus strains: comparison of clinical isolates from Northern and Southern Italy. [Epub ahead of print] Eur J Clin Microbiol Infect Dis 2011; http://dx.doi.org/10.1007/s10096-011-1350-7; PMID: 21796344
  • Iturriza-Gómara M, Green J, Brown DW, Desselberger U, Gray JJ. Diversity within the VP4 gene of rotavirus P[8] strains: implications for reverse transcription-PCR genotyping. J Clin Microbiol 2000; 38:898 - 901; PMID: 10655412
  • Simmonds MK, Armah G, Asmah R, Banerjee I, Damanka S, Esona M, et al. New oligonucleotide primers for P-typing of rotavirus strains: Strategies for typing previously untypeable strains. J Clin Virol 2008; 42:368 - 73; http://dx.doi.org/10.1016/j.jcv.2008.02.011; PMID: 18378188
  • Carvalho-Costa FA, Araújo IT, Santos de Assis RM, Fialho AM, de Assis Martins CM, Bóia MN, et al. Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil. Emerg Infect Dis 2009; 15:95 - 7; http://dx.doi.org/10.3201/eid1501.071136; PMID: 19116062
  • Correia JB, Patel MM, Nakagomi O, Montenegro FM, Germano EM, Correia NB, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 2010; 201:363 - 9; http://dx.doi.org/10.1086/649843; PMID: 20047501
  • Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757 - 63; http://dx.doi.org/10.1016/S0140-6736(07)61744-9; PMID: 18037080
  • De Vos B, Han HH, Bouckenooghe A, Debrus S, Gillard P, Ward R, et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J 2009; 28:261 - 6; http://dx.doi.org/10.1097/INF.0b013e3181907177; PMID: 19289978
  • Cilla G, Montes M, Gomariz M, Piñeiro L, Pérez-Trallero E. Rotavirus genotypes in children in the Basque Country (northern Spain) over a 13-year period (July 1996-June 2009). Eur J Clin Microbiol Infect Dis 2010; 29:955 - 60; http://dx.doi.org/10.1007/s10096-010-0951-x; PMID: 20490883
  • Koukou D, Grivea I, Roma E, Tsioni H, Trimis G, Galanakis E, et al, Greek Rotascore Extension Study Group. Frequency, clinical characteristics, and genotype distribution of rotavirus gastroenteritis in Greece (2007-2008). J Med Virol 2011; 83:165 - 9; http://dx.doi.org/10.1002/jmv.21945; PMID: 21108355
  • Mladenova Z, Korsun N, Geonova T, Iturriza-Gómara M, Group RS, Rotavirus Study Group. Molecular epidemiology of rotaviruses in Bulgaria: annual shift of the predominant genotype. Eur J Clin Microbiol Infect Dis 2010; 29:555 - 62; http://dx.doi.org/10.1007/s10096-010-0895-1; PMID: 20217165
  • Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s National Childhood vaccine schedule. Pediatr Infect Dis J 2011; 30:Suppl S25 - 9; http://dx.doi.org/10.1097/INF.0b013e3181fefdee; PMID: 21183837
  • do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med 2011; 8:e1001024; http://dx.doi.org/10.1371/journal.pmed.1001024; PMID: 21526228
  • Raes M, Strens D, Vergison A, Verghote M, Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011; 30:e120 - 5; http://dx.doi.org/10.1097/INF.0b013e318214b811; PMID: 21436757
  • Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, et al, National Rotavirus Strain Surveillance System. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011; 30:Suppl S42 - 7; http://dx.doi.org/10.1097/INF.0b013e3181fefd78; PMID: 21183839
  • Gómez MM, de Mendonça MC, Volotão EdeM, Tort LF, da Silva MF, Cristina J, et al. Rotavirus A genotype P[4]G2: genetic diversity and reassortment events among strains circulating in Brazil between 2005 and 2009. J Med Virol 2011; 83:1093 - 106; http://dx.doi.org/10.1002/jmv.22071; PMID: 21503926
  • Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, et al, Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11 - 22; http://dx.doi.org/10.1056/NEJMoa052434; PMID: 16394298
  • Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al, Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23 - 33; http://dx.doi.org/10.1056/NEJMoa052664; PMID: 16394299
  • Syriopoulou V, Kafetzis D, Theodoridou M, Syrogiannopoulos GA, Mantagos S, Trimis G, et al. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece. Acta Paediatr 2011; 100:732 - 9; http://dx.doi.org/10.1111/j.1651-2227.2010.02127.x; PMID: 21223372
  • Vesikari T, Van Damme P, Giaquinto C, Gray J, Mrukowicz J, Dagan R, et al, Expert Working Group, European Society for Paediatric Infectious Diseases, European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary. J Pediatr Gastroenterol Nutr 2008; 46:615 - 8; http://dx.doi.org/10.1097/MPG.0b013e31816e213a; PMID: 18493224
  • Clark HF, Borian FE, Bell LM, Modesto K, Gouvea V, Plotkin SA. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988; 158:570 - 87; http://dx.doi.org/10.1093/infdis/158.3.570; PMID: 2842405
  • Givon-Lavi N, Greenberg D, Dagan R. Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children. Vaccine 2008; 26:5798 - 801; http://dx.doi.org/10.1016/j.vaccine.2008.08.030; PMID: 18786584
  • Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30:1365 - 73; PMID: 1320625
  • Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990; 28:276 - 82; PMID: 2155916
  • Chouikha A, Fodha I, Ben Hadj Fredj M, Ardhaoui M, Teleb N, Brini I, et al. Relationship between electropherotypes and VP7/VP4 genotypes of group A rotaviruses detected between 2000 and 2007 in Tunisian children. Pathol Biol (Paris) 2011; 59:e43 - 8; http://dx.doi.org/10.1016/j.patbio.2009.04.008; PMID: 19481882

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.